Approval · Notice of Compliance 18752 · 2016
ATRIPLA: Notice of Compliance 18752
Issued November 16, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18752
- Date
- November 16, 2016
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the inner/outer bottle labels to adhere to current labelling standards
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATRIPLA | Not yet assigned | — |
Medicinal ingredients
- EFAVIRENZ 600 MG per TAB
- EMTRICITABINE 200 MG per TAB
- TENOFOVIR DISOPROXIL FUMARATE 300 MG per TAB